N🟁N

Alkermes Corporate Presentation to be Webcast at the NASDAQ Investor Program

  //health-fitness.news-articles.net/content/2008/ .. o-be-webcast-at-the-nasdaq-investor-program.html
  Published in Health and Fitness on Monday, November 24th 2008 at 14:25 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by NASDAQ International on Thursday, December 4, 2008 at 1:45 p.m. GMT (8:45 a.m. EST). The presentation will be webcast from the Renaissance Chancery Court Hotel in London and may be accessed under the investor relations tab at [ www.alkermes.com ]. The presentation will be archived for 14 days.

Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL^® CONSTA^® for schizophrenia and developed and manufactures VIVITROL^® for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.